Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675)

J.S.A. Belderbos*, D.K.M. De Ruysscher, K. De Jaeger, F. Koppe, M.L.F. Lambrecht, Y.N. Lievens, E.M.T. Dieleman, J.P.M. Jaspers, J.P. Van Meerbeeck, F. Ubbels, M.H. Kwint, M.A. Kuenen, S. Deprez, M.B. De Ruiter, W. Boogerd, K. Sikorska, H. Van Tinteren, S.B. Schagen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Web of Science)
Original languageEnglish
Pages (from-to)840-849
Number of pages10
JournalJournal of Thoracic Oncology
Volume16
Issue number5
DOIs
Publication statusPublished - 1 May 2021

Keywords

  • SCLC
  • Prophylactic cranial irradiation
  • Hippocampus
  • Neurocognition
  • PCI
  • NEUROCOGNITIVE FUNCTION
  • BRAIN METASTASES
  • NORMATIVE DATA
  • III TRIAL
  • RADIOTHERAPY

Cite this